Core Viewpoint - Renal anemia is a common complication in chronic kidney disease (CKD) patients, significantly affecting their quality of life and increasing the risk of cardiovascular events and mortality [1] Group 1: Disease Overview - Approximately 50% of CKD patients in China experience anemia, with incidence rates rising as kidney function deteriorates [1] - The underlying causes of renal anemia include insufficient erythropoietin (EPO) production, iron metabolism disorders, and inflammation [1] - Symptoms of renal anemia include fatigue, palpitations, and reduced exercise tolerance [1] Group 2: Treatment Challenges - Current treatment options include iron supplementation, erythropoiesis-stimulating agents (ESA), and oral HIF-PHI drugs [1] - Patients face challenges such as iron deficiency, ESA resistance, and poor treatment adherence [1] - Some patients delay diagnosis and treatment due to a lack of awareness or reliance on blood transfusions [1] Group 3: Expert Insights - A live session featuring experts in nephrology will be held to discuss the standardized diagnosis and treatment of renal anemia, aiming to help patients and families respond scientifically and improve quality of life [1][2]